Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-11-23
1997-07-01
Eisenschenk, Frank C.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
53038824, 5303891, 5303892, C07K 1624, C12N 512
Patent
active
056440340
ABSTRACT:
The present invention relates to ligands which bind to human tumour necrosis factor alpha (TNF) in a manner such that upon binding of these ligands to TNF the biological activity of TNF is modified. In preferred forms the ligand binds to TNF in a manner such that the induction of endothelial procoagulant activity of the TNF is inhibited; the binding of TNF to receptors on endothelial cells is inhibited; the induction of fibrin deposition in the tumor and tumor regression activities of the TNF are enhanced; and the cytotoxicity and receptor binding activities of the TNF are unaffected or enhanced on tumor cells. The ligand is preferably an antibody, F(ab) fragment, single domain antibody (dABs) single chain antibody or a serum binding protein. It is preferred, however, that the ligand is a monoclonal antibody or F(ab) fragment thereof.
REFERENCES:
Bringman et al., Hybridoma, 6(5):489, 1987.
Zwierzina, Stem Cells, 11:144-153, 1993.
Aston Roger
Rathjen Deborah Ann
Eisenschenk Frank C.
Peptide Technology Ltd.
LandOfFree
Tumour necrosis factor binding ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumour necrosis factor binding ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumour necrosis factor binding ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-598567